Evidence-based Interventions Programme List 3 will include 17 new interventions in England

31

Jan 2022

On January 20, 2022, the Academy of Medical Royal Colleges (AoMRC) launched a consultation on the latest set of guidance (List 3) of the Evidence-based Interventions (EBI) Programme. The deadline for comments submission is March 31, 2022.

EBI Programme is a joint enterprise between the AoMRC, NHS Clinical Commissioners, the National Institute for Health and Care Excellence (NICE) as well as NHS England and Improvement.

EBI program develops guidance sets (Lists) for tests, treatments, and procedures based on recommendations from the Expert Advisory Committee and NICE assessments. The guidance is aimed to support clinicians in improving patient outcomes and commissioners in developing their policies. List 1 (17 interventions) was published in 2018, List 2 (31 interventions) in 2020.

The guidelines provide clear, evidence-based criteria for consideration about the use of each intervention. The implementation of this proposed guidance would result in a reduction in unwarranted variation across England by standardizing the criteria.

Proposed List 3 covers 17 interventions across a range of medical specialties.

Breast Surgery:

  • Male gynecomastia reduction surgery;
  • Breast prosthesis removal;
  • Corrective surgery for congenital breast.

Cardiology: Angioplasty for PCI (percutaneous coronary intervention) in stable angina.

Endocrinology: Thyroid nodule referral and investigation.

Vascular:

  • Asymptomatic carotid artery stenosis screening;
  • Management of Abdominal Aortic Aneurysms (AAAs).

Gastrointestinal Surgery: Referral for bariatric surgery.

Ophthalmology:

  • Optical coherence tomography (OCT) use in diabetic retinopathy referral;
  • Shared decision-making for cataract surgery;
  • Glaucoma referral criteria.

Urology:

  • Non-visible haematuria;
  • Needle biopsy of the prostate;
  • Penile circumcision.

Plastic Surgery:

  • Abdominoplasty or Apronectomy;
  • Liposuction;
  • Diastasis recti repair.

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).

The latest related news

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

20

Jan 2023

In December 2022, the National Institute for Health and Care Research (NIHR) in England released six MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned laser therapy in diabetic macular oedema, EarlyCDT Lung blood test, video-assisted thoracoscopic or open lobectomy, urethral slings for stress urinary incontinence, placental growth factor (PlGF) and sFlt-1 tests, and photobiomodulation in the management of oral mucositis. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.

Read more

19

Jan 2023

On January 1, 2023, the annual update of the Finnish NordDRG system came into force. There are 947 DRGs in the 2023 DRG system, compared to 930 DRGs in 2022. Among other changes, 34 new DRGs were introduced, including the DRGs in the cardiovascular, endocrine, endoscopy, gastrointestinal, obstetrics and gynecology, orthopedics, peripheral vascular, surgical procedures, and some other fields.

Read more

17

Jan 2023

On December 23, 2022, NHS England published a preliminary 2023/25 NHS Payment Scheme and launched a consultation. NHS Payment Scheme will replace the National Tariff Payment System from April 1, 2023. The deadline for comments submission is January 27, 2023.

Read more

12

Jan 2023

In December 2022, the National Institute for Health and Care Excellence (NICE) published one new Medical Technologies Guidance (Memokath 051 Ureter stent for ureteric obstruction) and one MedTech Innovation Briefing (PromarkerD). Also, two new clinical guidelines were published, and one was updated.

Read more